Your browser doesn't support javascript.
Augmented interferon I signaling in a patient with COVID toes.
Komura, Kazuhiro; Ichimura, Yuki; Okiyama, Naoko; Watanabe, Kazuyoshi; Muramoto, Hiroaki; Matsushita, Takashi.
  • Komura K; Department of Dermatology, Japan Community Health Care Organization Kanazawa Hospital, Kanazawa, Japan.
  • Ichimura Y; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Okiyama N; Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Watanabe K; Department of Internal Medicine, Japan Community Health Care Organization Kanazawa Hospital, Kanazawa, Japan.
  • Muramoto H; Department of Internal Medicine, Japan Community Health Care Organization Kanazawa Hospital, Kanazawa, Japan.
  • Matsushita T; Department of Dermatology, Faculty of Medicine, Pharmaceutical Health Sciences, Kanazawa University, Kanazawa, Japan.
J Dermatol ; 48(5): e242-e243, 2021 May.
Article in English | MEDLINE | ID: covidwho-1142847
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Chilblains / COVID-19 Limits: Humans Language: English Journal: J Dermatol Year: 2021 Document Type: Article Affiliation country: 1346-8138.15864

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Chilblains / COVID-19 Limits: Humans Language: English Journal: J Dermatol Year: 2021 Document Type: Article Affiliation country: 1346-8138.15864